Malone Jim, Del Rosario Perez Maria, Friberg Eva Godske, Prokop Mathias, Jung Seung Eun, Griebel Jurgen, Ebdon-Jackson Steve
School of Medicine, Trinity Centre for Health Sciences, St James's Hospital, Dublin, Ireland.
Radiation Programme, Department of Public Health, Environmental and Social Determinants of Health, World Health Organization, Geneva, Switzerland.
J Am Coll Radiol. 2016 Dec;13(12 Pt A):1447-1457.e1. doi: 10.1016/j.jacr.2016.07.020.
An international expert consultation was convened by the World Health Organization (WHO). The purpose of the meeting was to review the use of CT in examining asymptomatic people. This is often referred to as individual health assessment (IHA). IHA was identified as a global phenomenon unenthusiastically tolerated, and not actively promoted, structured, or regulated in most countries. This paper identifies the state of the art for IHA and some considerations in relation to its justification, in different regions of the world. The outcomes reached include the following: questions around terminology and culture of IHA practice; review of IHA in some countries, regions, and international bodies; dilemmas for participants in IHA; risk communication, education, and training for professions and public; the desirability of guidelines and clinical audit; social, ethical, public health, and resource considerations; and a framework for IHA and regulatory considerations. Three subcategories of examination for asymptomatic individuals were identified: formal screening programs; examinations for which the evidence base or risk profile is incomplete; and opportunistic examinations with little or no evidence or risk profile to suggest they have any merit. The latter challenges the justification principle of radiation protection. In addition, the issue of the costs, direct and indirect, associated with false positives and/or equivocal/incidental findings were highlighted. These and other considerations make it difficult to view some IHA as a bona fide medical activity. To allow it to be viewed as such requires that it be conducted within a robust clinical governance framework that includes regulatory dimensions.
世界卫生组织(WHO)召集了一次国际专家咨询会。会议目的是审查CT在无症状人群检查中的应用。这通常被称为个体健康评估(IHA)。IHA被视为一种全球现象,在大多数国家,它只是被勉强容忍,并未得到积极推广、规范或管理。本文阐述了世界不同地区IHA的现状以及一些关于其合理性的考量。达成的成果包括:IHA实践的术语和文化相关问题;对一些国家、地区和国际机构中IHA的审查;IHA参与者面临的困境;针对专业人员和公众的风险沟通、教育及培训;制定指南和临床审计的必要性;社会、伦理、公共卫生及资源方面的考量;IHA框架及监管方面的考量。确定了针对无症状个体的三类检查:正式筛查项目;证据基础或风险状况不完整的检查;几乎没有证据或风险状况表明有价值的机会性检查。后者对辐射防护的正当性原则提出了挑战。此外,还强调了与假阳性和/或模棱两可/偶然发现相关的直接和间接成本问题。这些以及其他考量因素使得很难将某些IHA视为真正的医疗活动。要使其被视为真正的医疗活动,就需要在一个包括监管层面的强大临床治理框架内进行。